Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.08
-0.20 (-6.10%)
At close: Aug 14, 2025, 3:59 PM
2.90
-5.69%
After-hours: Aug 14, 2025, 05:45 PM EDT
-6.10% (1D)
| Bid | 2.9 |
| Market Cap | 42.52M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.37M |
| EPS (ttm) | -0.76 |
| PE Ratio (ttm) | -4.05 |
| Forward PE | -3.9 |
| Analyst | Buy |
| Ask | 3.13 |
| Volume | 179,681 |
| Avg. Volume (20D) | 56,977 |
| Open | 3.30 |
| Previous Close | 3.28 |
| Day's Range | 2.93 - 3.40 |
| 52-Week Range | 1.75 - 4.97 |
| Beta | 0.72 |
About GRCE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRCE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GRCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+8.33%
Grace Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
